FINANCIAL CALENDAR FOR SCN 2009

The Board of Scandinavian Clinical Nutrition i Sverige AB (publ) has decided on a few changes in the financial calendar, resulting in the following calendar for 2009:

February 27 Year-end Report and Interim Report October-December (Q4, 2008)

April 29 Annual Report 2008

May 15 Interim Report January-March (Q1, 2009)

June 26 Annual General Meeting 2008

August 28 Interim Report April-June (Q2, 2009)

November 13 Interim Report July-September (Q3, 2009)

February 26, 2010 Year-end Report and Interim Report October-December (Q4, 2009)

For more information, please contact:

Ulf Söderberg, CEO, us@scnutrition.com, +46 708 13 22 81

Jörn Erik Aas, Chairman of the Board, jea@scnutrition.com, +47 924 99 360

Scandinavian Clinical Nutrition AB (publ) works in R&D and distribution of clinically tested, scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Coldizin, Immulina, Membra7 and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and clinically proven products, create good conditions for profitable growth both in Sweden and internationally. The shares of SCN are traded under the ticker “SCN” on Oslo Axess (www.osloaxess.no) and NGM Equity (www.ngm.se).For more information, please visit www.scnutrition.com.